Tamilong 20mg Tablets

Tamoxifen Citrate belongs to a class of medications known as selective estrogen receptor modulators (SERMs), which work by binding to estrogen receptors on breast cells and blocking estrogen from attaching and stimulating cancer cell growth. Since many breast cancers rely on estrogen to grow, this action helps slow or stop the progression of hormone receptor-positive breast cancer. It is commonly used in both premenopausal and postmenopausal women with early-stage or advanced breast cancer, often as part of adjuvant therapy following surgery to help reduce the risk of cancer recurrence. Tamoxifen is also used as a preventive treatment for women at high risk of developing breast cancer, helping reduce their overall risk based on individual risk factors. Unlike aromatase inhibitors, Tamoxifen works directly at the estrogen receptor level rather than reducing estrogen production, making it suitable for use in women regardless of menopausal status. The medication is taken orally, usually once daily, often continued for five to ten years as part of long-term hormone therapy following initial breast cancer treatment. Regular monitoring, including periodic gynecological exams and eye checks, is an important part of treatment to help support overall health during long-term use. Many patients experience meaningful reduction in cancer recurrence risk and improved long-term outcomes with consistent use of Tamoxifen. As with all hormone therapies for cancer treatment, Tamoxifen Citrate should be used under the close supervision of a healthcare provider experienced in breast cancer care.